Fingerprint
Dive into the research topics of 'Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: Correlation of Smad4(Dpc4) immunostaining with pattern of disease progression'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically